Creative Biolabs delivers fit-for-purpose protein and amino acid analytics that help live biotherapeutic product teams quantify functional proteins, characterize amino acid composition, and compare batches for identity, potency, stability, and process decisions. Our scientists integrate orthogonal assays, method suitability, and specification guidance to turn complex microbial samples into reliable development evidence.
Live biotherapeutic analytical development teams, engineered-strain programs, and QC groups often need to measure proteins in matrices that change with growth phase, media composition, cell lysis, and sample handling. Variable secretion, proteolysis, and background proteins can make an apparently simple concentration result difficult to interpret across development batches. Without a controlled sample pathway, biological change can be confused with extraction loss, assay interference, or protein breakdown during handling.
A useful analytical strategy must connect each measurement to a decision: confirming identity, tracking a functional product, understanding degradation, comparing production conditions, or setting a practical control range. Creative Biolabs provides protein and amino acid analysis services that combine orthogonal methods, sample-aware development, and clear reporting for live biotherapeutic products.
Measure
Total protein, target protein, and amino acid composition
Understand
Identity, purity, secretion, degradation, and matrix effects
Decide
Compare batches and define fit-for-purpose controls
Creative Biolabs supports analytical development and method qualification for microbial drug candidates, engineered strains, fermentation intermediates, cell pellets, lysates, supernatants, and formulated LBP samples. We build an integrated test plan around the analyte, matrix, development stage, and decision the result must support.
Protein expression and amino acid composition can support identity, functional characterization, process understanding, stability assessment, and batch comparability. The analytical question determines the method combination.
We assess total protein and specific protein levels in relevant fractions using appropriate colorimetric, immunochemical, or chromatographic approaches. Development can address calibration strategy, dilution linearity, recovery, dynamic range, sample normalization, and matrix interference so that reported values remain interpretable across runs and batches.
SDS-PAGE supports protein-pattern, apparent molecular-weight, purity, and degradation observations, while Western blotting provides target-specific confirmation. We can establish ELISA procedures when quantitative immunodetection is appropriate, including reagent selection, curve design, sample preparation, precision checks, and controls suited to the microbial matrix.
Amino acid analysis can characterize hydrolyzed protein samples, assess amino acid content in raw materials or process inputs, and provide composition-based support for protein identity and content. Study design accounts for hydrolysis conditions, labile residues, derivatization, standards, and the reporting basis needed for meaningful comparison.
High-performance liquid chromatography (HPLC) can support separation and quantitative analysis of suitable targets, while MALDI-TOF mass spectrometry and broader proteomic approaches help identify protein signatures or investigate complex protein populations. The platform is selected according to specificity, sensitivity, throughput, and sample complexity rather than by instrument alone.
For engineered strains and functionally protein-driven programs, we compare cell-associated and extracellular fractions, examine release or secretion patterns, and monitor loss or fragmentation under relevant hold, process, and storage conditions. Controls help distinguish intended secretion from release caused by lysis and help identify where sample handling may distort the apparent protein profile.
| Analytical Need | Applicable Techniques | Development Value |
|---|---|---|
| Protein amount | Total protein assay, ELISA, HPLC | Quantifies expression or content and supports normalization |
| Purity and identity | SDS-PAGE, Western blot, MALDI-TOF MS | Confirms expected signal and reveals unexpected bands or variants |
| Amino acid composition | Hydrolysis, derivatization, chromatographic quantitation | Supports composition, identity, raw-material, or nutritional assessments |
| Complex protein profiles | Proteomics, mass spectrometry, multivariate comparison | Detects condition- or batch-associated profile changes |
| Secretion and degradation | Fractionation plus orthogonal detection | Separates location, recovery, lysis, and stability effects |
Our workflow keeps the biological question, sample pathway, analytical controls, and final decision connected from protocol design through reporting.
Define analyte, matrix, sample fractions, expected range, and development decision.
Screen extraction, recovery, specificity, sensitivity, and matrix interference.
Optimize preparation, controls, standards, assay conditions, and calculations.
Analyze study samples with predefined suitability and acceptance checks.
Compare groups, document limitations, and recommend next analytical steps.
Deliverables are tailored to the agreed study stage and may range from feasibility findings to a qualified analytical procedure and structured batch-comparison package.
A sample- and decision-specific plan covering preparation, method selection, controls, standards, acceptance logic, and known risks.
Documented observations for specificity, precision, linearity, range, recovery, robustness, or other characteristics appropriate to intended use.
Traceable sample results, standard and control performance, gel or blot images where applicable, chromatograms, spectra, and comparison plots.
Side-by-side assessment of production lots, culture conditions, time points, fractions, formulations, or storage conditions using agreed metrics.
Clear documentation of matrix effects, recovery concerns, assay variability, unexpected signals, or other factors that affect interpretation.
Science-based suggestions for attributes, reporting units, control strategy, and provisional ranges, subject to development stage and available batch history.
Recent research on Lacticaseibacillus rhamnosus GG showed that fermentable carbon sources can reshape both microbial growth and the global protein profile. The figure combines growth curves with principal component analysis and a mass-spectrometry intensity heat map, showing that culture conditions can produce clearly distinguishable proteomic patterns. This evidence matters for LBP analytics because protein abundance is not a static strain property; media composition and metabolic state can influence the measured product profile.
For development and QC teams, the published data reinforce the need to control sample context, use qualified preparation procedures, and compare batches with orthogonal analytical readouts. A single total-protein value may miss relevant shifts in individual proteins, secretion, or degradation. Creative Biolabs supports fit-for-purpose protein quantitation, electrophoretic and immunochemical analysis, chromatographic testing, and proteomic comparison so clients can connect observed protein changes to process understanding, identity, stability, and functional assay strategy.
More than ten years of experience in biological pharmaceutical development gives our team the perspective to connect analytical performance with the practical needs of varied microbial products.
Qualitative and quantitative analysis across total protein, target protein, amino acids, and proteome profiles.
Sample strategies designed for varied live biotherapeutic strains, matrices, process stages, and engineered products.
Electrophoresis, immunoassays, chromatography, and mass spectrometry selected to answer the analytical question.
Clear study communication, timely updates, efficient turnaround planning, and reliable technical reports.
We can execute an established protocol or help design a method around your analyte, sample type, and intended use. This flexible model gives teams a practical route from early feasibility to routine testing without forcing every project into the same analytical package. Scope-aligned study design also helps avoid unnecessary testing and supports cost-conscious development.
Share your strain, sample matrix, target protein, existing method, and development decision. Our scientists will help define a focused analytical starting point.
Protein and amino acid measurements are often most informative when linked with broader QC, cell-based function, potency, and stability evidence. These services can extend the analytical package around your product's critical attributes.
Depending on the target and method, studies may use cell pellets, whole-cell preparations, lysates, culture supernatants, process intermediates, raw materials, formulated products, or separated cellular and extracellular fractions. Feasibility work defines the preparation and controls required for each matrix.
The study can combine controlled fractionation with cell integrity or lysis indicators, fraction-specific controls, target detection, and time-course sampling. The final design depends on the organism, expected localization, culture conditions, and sensitivity of the selected method.
Yes. We can begin with a client protocol and assess its suitability in the relevant LBP matrix. Work may focus on transfer, troubleshooting, optimization, or qualification, with attention to standards, controls, specificity, recovery, range, precision, and robustness as appropriate.
Proteomics is useful when the relevant marker is not yet fixed, when multiple proteins may contribute to the phenotype, or when teams need a broad comparison across strains, batches, culture conditions, or fractions. Target-specific assays are generally better for focused routine measurement once the analyte is defined.
Yes. With aligned sampling, controls, and acceptance logic, protein concentration, target-specific signal, electrophoretic profile, chromatographic behavior, or proteomic patterns can be compared across batches and time points. Method suitability and sufficient batch history are important before setting formal specifications.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.
